BCM
ELOX

Bridgeway Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bridgeway Capital Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,623
Closed -$38K – 1492
2022
Q3 		$38K Sell
5,623
-612
-10% -$7.36K ﹤0.01% 1364
2022
Q2 		$67K Sell
6,235
-1,500
-19% -$20.7K ﹤0.01% 1264
2022
Q1 		$173K Hold
7,735
– – ﹤0.01% 1193
2021
Q4 		$217K Buy
7,735
+5,450
+239% +$238K ﹤0.01% 1152
2021
Q3 		$149K Sell
2,285
-1,440
-39% -$88.8K ﹤0.01% 1229
2021
Q2 		$297K Sell
3,725
-545
-13% -$45.5K 0.01% 1210
2021
Q1 		$567K Hold
4,270
– – 0.01% 1058
2020
Q4 		$680K Sell
4,270
-125
-3% -$15.3K 0.01% 850
2020
Q3 		$462K Hold
4,395
– – 0.01% 919
2020
Q2 		$533K Buy
4,395
+1,997
+83% +$226K 0.01% 837
2020
Q1 		$188K Sell
2,398
-750
-24% -$122K ﹤0.01% 1075
2019
Q4 		$927K Buy
+3,148
New +$634K 0.01% 760

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bridgeway Capital Management's ELOX Position: Q4 2022 in Review

Bridgeway Capital Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 5,623 shares — an estimated $38K sold.

Bridgeway Capital Management first reported a position in ELOX in Q4 2019 and held it in 12 quarters. The position peaked at $927K in Q4 2019. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Bridgeway Capital Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 5,623 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $38K.
  • Bridgeway Capital Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Bridgeway Capital Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $927K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.